Latest news
Loading news…
Immunitas Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2019 11-50 employees For Profit
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
43
Patents
6
6 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 6
- Trademarks
- 6
- Top patent class
- Organic Chemistry
- IT spend
- $70K
Company Info
- Founded
- 2019
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 5
- News articles
- 38
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.6
- Trend (30d)
- -2.3
- Trend (90d)
- -1.2
- Last leadership hire
- Jan 18, 2024
Key People at Immunitas Therapeutics
Chief Medical Officer
Chief Executive Officer
Chief Operating Officer
Chief Scientific Officer
Chief Scientific Officer
43
professional contacts at Immunitas Therapeutics
Contact execs at Immunitas Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Immunitas Therapeutics
Loading news…
FAQs about Immunitas Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.